Dennis J Fortino Net Worth

The estimated Net Worth of Dennis J Fortino is at least $1.87 Million dollars as of 29 January 2004. Dennis Fortino owns over 47,749 units of Novanta Inc stock worth over $1,872,905 and over the last 21 years Dennis sold NOVT stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Dennis Fortino NOVT stock SEC Form 4 insiders trading

Dennis has made over 2 trades of the Novanta Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently Dennis exercised 47,749 units of NOVT stock worth $1,587,177 on 29 January 2004.

The largest trade Dennis's ever made was exercising 47,749 units of Novanta Inc stock on 29 January 2004 worth over $1,587,177. On average, Dennis trades about 10,443 units every 23 days since 2003. As of 29 January 2004 Dennis still owns at least 11,215 units of Novanta Inc stock.

You can see the complete history of Dennis Fortino stock trades at the bottom of the page.

What's Dennis Fortino's mailing address?

Dennis's mailing address filed with the SEC is , , , , .

Insiders trading at Novanta Inc

Over the last 8 years, insiders at Novanta Inc have traded over $115,059,741 worth of Novanta Inc stock. The most active insiders traders include Stephen W Bershad, Ira J Lamel, and Matthijs Glastra. On average, Novanta Inc executives and independent directors trade stock every 15 days with the average trade being worth of $1,701,396. The most recent stock trade was executed by Robert Buckley on 3 September 2024, trading 4,379 units of NOVT stock currently worth $61,875.

What does Novanta Inc do?

novanta (nasdaq: novt) delivers innovations that matter for its medical and advanced industrial oem customers. if you have a passion for solving complex technical problems that lead to breakthrough performance and that enhance people's lives, come join our growing team. here is a sample of the many exciting applications we serve: • innovations that ensure the safety of patients and efficient workflows in hospitals using our novel rfid technology • innovations in additive manufacturing, also known as 3-d metal printing, using our lightning fast lasers and laser beam steering sub-systems • innovations in minimally invasive surgery using our highly reliable insufflators, pumps and visualization systems • innovations in robotics and automation using our precision motors, encoders and drives for superior accuracy • innovations in smartphone production using our fast, accurate lasers and laser beam steering equipment along with our precision motion systems the driving force behind our grow

Complete history of Dennis Fortino stock trades at KLA and Novanta Inc

Novanta Inc executives and stock owners

Novanta Inc executives and other stock owners filed with the SEC include:

• Matthijs Glastra,
  Chief Executive Officer, Director
• Robert Buckley,
  Chief Financial Officer
• Matthijs Glastra,
  CEO & Chairman
• Brian Young,
  Chief Human Resource Officer
• Robert J. Buckley,
  Chief Financial Officer
• Brian S. Young,
  Chief HR Officer
• Stephen Bershad,
  Independent Chairman of the Board
• Ira Lamel,
  Independent Director
• Thomas Secor,
  Independent Director
• Brian King,
  Independent Director
• Lonny Carpenter,
  Independent Director
• Deborah Eldracher,
  Independent Director
• Ray Nash,
  Corp. Fin. Leader
• Heinrich Dreyer,
  Group Pres of Vision
• Charlie Webster,
  Exec. VP of Novanta Growth System & Global Supply Chain
• Kitty Sahin,
  Exec. VP of Strategy & Bus. Devel.
• Sarah Betadam,
  Chief Information Officer
• Peter L. Chang,
  Corp. Controller & Chief Accounting Officer
• Harry L Bosco,
  Director
• John A Roush,
  Chief Executive Officer
• Dominic A Romeo,
  Director
• Dennis J Fortino,
  Director
• Peter L Chang,
  CAO-Corporate Controller
• Frank Anders Wilson,
  Director
• Darlene J. S. Solomon,
  Director
• Mary Kay Ladone,
  Director
• Maxine Lum Mauricio,
  Director
• Katherine Ann Owen,
  Director
• Robert Matthew Johnson,
  Director
• Barbara B. Hulit,
  Director
• Michele Davis Welsh,
  General Counsel